BackAtossa Therapeutics Overview

Atossa Therapeutics Current Cash

Track Atossa Therapeutics's current cash ($26M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$26.09M
↓ 54.90% YoYΔ $-31.76M vs prior year quarter

Peer trimmed avg / median

Loading

Atossa Therapeutics Current Cash History

Loading

Atossa Therapeutics vs. peers: Current Cash Comparison

Loading

Atossa Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Atossa Therapeutics (ATOS) FAQ

The latest current cash for ATOS is $26M as of June 2026. That compares with $58M in the prior-year period — down 54.9% year over year. Investors often review this figure alongside Atossa Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, ATOS's current cash moved from $58M to $26M — a 54.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Atossa Therapeutics's operating scale or balance-sheet position.

A current cash figure of $26M for ATOS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ATOS's current cash ($26M), review year-over-year change from $58M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Atossa Therapeutics's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.